Skip to content

Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia

Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia Results of Investigations on 3,491 Catheters

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00251654
Enrollment
9000
Registered
2005-11-10
Start date
2002-01-31
Completion date
2008-12-31
Last updated
2009-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Effects, Infection, Inflammation

Keywords

complications, adverse events, regional anesthesia, adverse effects

Brief summary

The investigators prospectively document infectious, neurological, and other complications or adverse events occurring during peripheral regional anesthesia via a catheter using computer-based data recording.

Detailed description

Perineural blocks with catheter placement are more and more frequently used. Few data dealing with infectious complications of perineural catheters exist. We assess incidence and localization of infectious complications of perineural catheters by means of computerized data acquisition. We prospectively evaluate perineural catheters placed at different sites for regional anesthesia and postoperative analgesia. The catheters were placed under standardized sterile conditions by using the nerve stimulator technique. Local inflammation is defined as the presence of at least two of the three signs: redness, pain on pressure or swelling. Infection is defined as the presence of at least two of the following criteria: pus at the catheter insertion site, fever, increased CRP and/or leukocytes requiring antibiotic therapy.

Interventions

PROCEDUREperineural block (anesthesia)

continuous peripheral regional anesthesia ropivacaine 0.33% for 3 to 5 days

Sponsors

BG Unfallklinik Murnau
CollaboratorOTHER
Rechbergklinik Bretten
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients receiving perineural blocks via catheter

Exclusion criteria

* None

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026